LONDON & LOS ANGELES–(BUSINESS WIRE)–Crescent Capital Group LP, a number one various credit score funding agency, introduced right this moment that its European Specialty Lending technique has offered unitranche financing to help the recapitalisation of Frontier Medical, a UK-based producer of medical gadgets specialised within the stress ulcer prevention section.
Kester Capital acquired Frontier Medical Group in 2013 and has helped it to develop from a profitable family-owned enterprise into a world medical gadget enterprise with vital income, EBITDA and head rely will increase since its funding. Headquartered in Blackwood, Wales, and based in 1966, Frontier Medical has grown to grow to be a number one producer and provider of stress ulcer prevention merchandise to healthcare suppliers within the UK in addition to export markets world wide.
“As a globally-renowned producer and innovator within the rising discipline of medical gadgets, Frontier has proven the flexibility to develop by way of revolutionary gadgets, and our expectation is for its enlargement and relevancy to proceed,” mentioned Christine Vanden Beukel, Managing Director and head of Crescent’s European Specialty Lending technique. “This transaction is our second to date this 12 months with Kester Capital, and we’re excited so as to add them to our roster of main sponsors who come to Crescent for its capacity to offer versatile capital and tailored options.”
Frontier Medical received the award for “Enterprise Transformation Administration Group” on the BVCA Wales Administration Group Awards 2019 and was additionally included in The London Inventory Change Group’s “1000 Firms to Encourage Britain 2019,” an annual celebration of among the fastest-growing and most dynamic small- and medium-sized enterprises within the UK. Frontier Medical additionally received the inaugural Nationwide BVCA “Accountable Portfolio Firm Award” in 2017.
About Crescent Capital Group
Crescent Capital Group is headquartered in Los Angeles with places of work in Boston, London, and New York. With greater than 85 funding professionals and roughly 180 staff, the agency invests in any respect ranges of the capital construction, with a big give attention to beneath funding grade credit score by way of methods that put money into senior financial institution loans, unitranche loans, excessive yield debt, mezzanine debt, and different non-public debt securities. As of December 31, 2020, Crescent Capital Group managed roughly $30 billion, with a comparatively equal cut up between marketable securities and privately originated debt investments. For extra details about Crescent Capital Group, go to www.crescentcap.com.
About Kester Capital
Kester Capital is a major buy-out specialist, led by entrepreneurial and skilled traders, and targeted on UK companies that require capital with a purpose to unlock their potential. Established in 2007, Kester has been making European non-public fairness investments targeted on Healthcare, Enterprise & Monetary Companies, TMT and Area of interest Client. For extra data, please go to http://www.kestercapital.com.